851 ANTIVIRAL POTENCY OF R1479, ACTIVE COMPOUND DERIVED IN VIVO FROM PRODRUG R1626, DEMONSTRATED ACROSS HCV GENOTYPES 1-6 IN NS5B RECOMBINANT ENZYMES AND HCV REPLICONS
V. Leveque, S. Le Pogam, H. Kang, G. Ao-Ieong, A. Kosaka, A. Seshaadri, J. Symons, N. Cammack, K. Klumpp, I. NajeraVolume:
48
Year:
2008
Language:
english
DOI:
10.1016/s0168-8278(08)60853-3
File:
PDF, 53 KB
english, 2008